Strategic partnerships Gene by Gene has a history of collaborations with key industry players such as Verogen and BC Platforms, indicating openness to ecosystem partnerships that could accelerate forensic and clinical genetics initiatives.

Scale and automation With over two decades of service innovation and robotic automation in a high‑capacity lab, there is a strong opportunity to upsell expanded testing panels, higher-throughput services, and integrated data workflows to larger clinical and research clients.

Data and analytics Adoption of modern data tooling (Snowflake, Power BI, Smartsheet, DBT, Jenkins, AWS) suggests readiness for advanced analytics, dashboards, and AI/ML powered decision support for partners requiring genomic data interpretation and operational insights.

Competitive pricing The emphasis on competitive pricing alongside fast turnaround positions Gene by Gene as a value alternative for budget‑constrained laboratories or clinics seeking rapid genetic testing capabilities without sacrificing quality.

Market positioning Operating from Houston with a global outlook and participation in events like HLTH Europe indicates a growth‑oriented sales motion targeting international markets, forensic applications, and multi‑disciplinary genetics services.